Article
Clinicopathologic features of endometrial cancer with mismatch repair deficiency
18 Jun 2020
Abstract excerpt
The inclusion of DNA mismatch repair (MMR) evaluation as a standard of care for endometrial cancer management will result in a growing population of patients with MMR deficiency and negative germline Lynch syndrome testing (MMR-deficient). In this systematic review and study, the clinicopathologic features of endometrial cancer in patients with MMR-intact, MLH1 methylation positive, MMR-deficient or Lynch...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
